Adrastia Biotechnology was founded in 2013 to provide a highly accurate Breast Cancer diagnostic protocol that is easy to administer, non-invasive, will deliver rapid results, and provide women with a personal health history.
Adrastia Biotechnology obtains the urine sample and runs high throughput protein quantification and targeted mRNA/microRNA sequencing to identify a pattern of breast cancer positive or negative as compared to a standard or the woman’s own previous pattern. Unlike 100% genomic data, Adrastia’s test results are designed to be actionable by the woman’s physician and her pattern will be stored in her health record for future reference.
Cesca Therapeutics is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine. We focus in three target markets to serve patients, physicians and partners:
Medical/Diagnostic Device Development and Commercialization
Cell Manufacturing and Banking
Have you ever had a surgery?
Checking out of the hospital, you were likely you were given a list of products to help you recover.
Easy DME allows clinics to offer all of the products a patient needs to recover, delivered directly to their doorstep.
No more product scavenger hunts.
Easy DME helps clinics to increase revenue while adding a new convenient service to increase patient satisfaction.
We are addressing the opioid crisis in America and the vast unmet medical needs in pain management by developing a new class of pain drugs that was discovered by accident during our search for new and better general anesthetics. We are also working to reduce anesthetic costs and bring general anesthesia to the third of the world that lacks access through the development of new and better agents.
Safer Lock is the first combination locking cap for prescription pill bottles. Protect your children and family members from accidental poisoning and prevent prescription drug addiction by securing your medication and supplements in a Safer Lock bottle.
Juno Biomedical develops novel regenerative medical devices and therapies that harness the power of cell electrotaxis to repair brain damage caused by neurological disease and trauma.
The Kura MD telemedicine platform enables convenient, secure, HIPAA compliant telehealth appointments between physicians and patients through a computer, smart phone or tablet 24 hours a day, seven days a week. Kura MD represents a new standard in telehealth services incorporating electronic medical records (EMR), an interface hub, registration system, verification, billing, claims, video conferencing, and integration of peripheral equipment, practice management and an optional best-in-class health station.
From the start, our team focused on improving the breastfeeding experience. Initially, we wanted to redesign the breast pump.
When Anna, our co-founder and CEO, interned in Brazil, she learned about different manual breast massage techniques that can help mothers express milk, increase milk supply, and alleviate pain from engorgement. That’s when we realized that we cannot keep putting technology between the mom and the baby. Instead, we need to initiate a breastfeeding culture shift in the United States.
Our goal is to improve the breastfeeding experience by discovering, testing, and teaching evidence-based breast massage techniques to parents and health providers.
Molecular Matrix, Inc. is focused on providing advanced research tools for cultivating and studying stem cells. Our products provide cutting edge solutions for growing cells in three dimensions. Our GroCell-3D™ product portfolio is comprised of 3D Scaffolds in various configurations, a cost effective dynamic cell culture system, and a solution to dissolve the scaffold and recover cells.